

Ellis J, Groppelli E, Doyle R, et al. Epstein–Barr virus and cytomegalovirus co-infections and mortality risk in patients with HIV-associated cryptococcal meningitis: a post-hoc analysis of a prospective nested cohort in the AMBITION-cm randomised controlled trial. Lancet HIV 2025; 12: e691–700—In table 3 of this Article, the fourth and fifth row subheadings should have read “Low-level cytomegalovirus viraemia (<1000 copies per mL)” and “High-level cytomegalovirus viraemia (≥1000 copies per mL)”.
HIV
|15th Jan, 2026
|The Lancet
HIV
|15th Jan, 2026
|The Lancet
HIV
|15th Jan, 2026
|The Lancet
HIV
|15th Jan, 2026
|The Lancet
HIV
|15th Jan, 2026
|The Lancet
HIV
|15th Jan, 2026
|The Lancet
HIV
|15th Jan, 2026
|The Lancet